Choriocapillaris Changes Imaged by OCT Angiography After Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引：23
|
作者：
Fujita, Kyoko [1 ]
Kawamura, Akiyuki [2 ]
Yuzawa, Mitsuko [2 ]
机构：
[1] Kansai Med Univ, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan
[2] Nihon Univ, Chiyoda Ku, Tokyo, Japan
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词：
INDOCYANINE GREEN ANGIOGRAPHY; VERTEPORFIN; LEVEL;
D O I：
10.3928/23258160-20170329-04
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
BACKGROUND AND OBJECTIVE: To evaluate the choriocapillaris using optical coherence tomographic angiography (OCTA) after half-dose verteporfin photodynamic therapy (hd-PDT) for chronic central serous chorioretinopathy (CSC). PATIENTS AND METHODS: We studied six eyes (six patients) with chronic CSC treated by hd-PDT. OCTA was performed before, 1 week after, and 1 month after hd-PDT. The area of flow abnormality at the choriocapillaris level within the PDT spot after hd-PDT was compared with that before hd-PDT. RESULTS: Serous retinal detachment was diminished in all eyes, with three achieving complete resolution at 1 month. On OCTA, all eyes showed irregular choriocapillaris flow before hd-PDT. The areas of abnormal flow shrank progressively at 1 month after hd-PDT. CONCLUSION: On OCTA, choriocapillaris flow tended to recover at 1 month after hd-PDT. OCTA may be clinically useful for evaluating choriocapillaris and the therapeutic effects of hd-PDT for chronic CSC.
引用
收藏
页码：302 / 310
页数：9
相关论文
共 50 条
  • [31] Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
    Ratanasukon, Mansing
    Thongthong, Koblarp
    Bhurayanontachai, Patama
    Jirarattanasopa, Pichai
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 87 - 92
  • [32] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863
  • [33] Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
    Horiguchi, Etsuyo
    Takeuchi, Jun
    Tomita, Ryo
    Asai, Keiko
    Nakano, Yuyako
    Ota, Hikaru
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy
    Izumi, Takahiko
    Koizumi, Hideki
    Maruko, Ichiro
    Takahashi, Yohei
    Sonoda, Shozo
    Sakamoto, Taiji
    Iida, Tomohiro
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (04) : 433 - 437
  • [35] Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
    Karakus, S. H.
    Basarir, B.
    Pinarci, E. Y.
    Kirandi, E. U.
    Demirok, A.
    EYE, 2013, 27 (05) : 612 - 620
  • [36] Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
    S H Karakus
    B Basarir
    E Y Pinarci
    E U Kirandi
    A Demirok
    Eye, 2013, 27 : 612 - 620
  • [37] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Yu-Te Huang
    Peng-Tai Tien
    Po-Yu Chen
    Chi-Lan Yang
    San-Ni Chen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 1755 - 1763
  • [38] Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy A case report
    Zhang, Zhengwei
    Bao, Xiaona
    Wu, Zhifeng
    Zhang, Jie
    MEDICINE, 2021, 100 (07) : E24790
  • [39] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Huang, Yu-Te
    Tien, Peng-Tai
    Chen, Po-Yu
    Yang, Chi-Lan
    Chen, San-Ni
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (06) : 1755 - 1763
  • [40] One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Hashizume, Kouhei
    Mizota, Atsushi
    Yuzawa, Mitsuko
    OPHTHALMOLOGY, 2015, 122 (03) : 555 - 561
12345